TROW
47
-6
ALLE
37
-4
PSA
56
3
CI
45
-3
VRSN
53
-5
NSC
53
-4
TXN
43
-5
OXY
36
-2
HRB
59
2
VZ
44
4
EFX
30
-8
CVX
43
-3
BEN
50
9
INTU
58
-3
WMB
68
2
GM
74
5
APH
65
-3
TDC
67
-4
JWN
48
-2
HRL
35
-3
TROW
47
-6
ALLE
37
-4
PSA
56
3
CI
45
-3
VRSN
53
-5
NSC
53
-4
TXN
43
-5
OXY
36
-2
HRB
59
2
VZ
44
4
EFX
30
-8
CVX
43
-3
BEN
50
9
INTU
58
-3
WMB
68
2
GM
74
5
APH
65
-3
TDC
67
-4
JWN
48
-2
HRL
35
-3
Financhill
Back

Invesco S&P 500® Eql Wt Cnsm Stapl ETF Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
22

RSPS
Invesco S&P 500® Eql Wt Cnsm Stapl ETF

Last Price:
30.71
Seasonality Move:
2.88%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
22
Invesco S&P 500® Eql Wt Cnsm Stapl ETF (RSPS) is a Sell

Is Invesco S&P 500® Eql Wt Cnsm Stapl ETF a Buy, Sell or Hold?

  • The current Invesco S&P 500® Eql Wt Cnsm Stapl ETF [RSPS] share price is $30.68. The Score for RSPS is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
  • RSPS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RSPS Stock Price Chart

What is Invesco S&P 500® Eql Wt Cnsm Stapl ETF's stock price today?

  • The Invesco S&P 500® Eql Wt Cnsm Stapl ETF share price today is $30.68
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RSPS is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

RSPS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.25 Sell
Relative Strength Index (14 RSI): 33.84 Sell
Chaikin Money Flow: -19846 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (30.9 - 31.86) Sell
Bollinger Bands (100): (30.93 - 32.23) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

RSPS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 30.93 Sell
20-day SMA: 31.2 Sell
50-day SMA: 31.76 Sell
200-day SMA: 31.68 Sell
8-day EMA: 30.96 Sell
20-day EMA: 31.19 Sell
50-day EMA: 31.51 Sell
200-day EMA: 31.64 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Invesco S&P 500® Eql Wt Cnsm Stapl ETF Earnings Growth & RSPS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

Invesco S&P 500® Eql Wt Cnsm Stapl ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):